product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
CD83 Antibody (101) [Janelia Fluor® 669]
catalog :
NBP3-12771JF669
quantity :
0.1 ml
price :
519 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
101
reactivity :
human, mouse
application :
flow cytometry
more info or order :
product information
brand :
Novus
master code :
NBP3-12771JF669
SKU :
NBP3-12771JF669
product name :
CD83 Antibody (101) [Janelia Fluor® 669]
sizes available :
0.1 ml
description :
The CD83 Antibody (101) [Janelia Fluor® 669] from NBP3-12771JF669 is a 6.7e-05 antibody to . This antibody reacts with mouse.
target :
CD83
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
101
conjugate :
Janelia Fluor 669
all_available conjugate :
DyLight 594;Janelia Fluor 669
dilution :
Flow Cytometry
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Mouse CD83 (Uniprot#: O88324; Met1-Arg133).
isotype :
IgG
purity :
Protein A purified
species :
Mouse
gene symbol :
CD83
applications :
Flow Cytometry
extended description :
Recombinant Monoclonal Antibody
USD :
519 USD
product details :
Recombinant Monoclonal Antibody
alt names :
B-cell activation protein, BL11CD83 antigen, CD83 antigen (activated B lymphocytes, immunoglobulin superfamily), CD83 molecule, Cell surface protein HB15, cell-surface glycoprotein, HB15hCD83
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
